The CHOICES Study: Facility Level Comparative Cost, Resource Utilization, and Outcomes Analysis of Myomectomy Compared to Transcervical Fibroid Ablation.

Elizabeth A BrooksAllison M SingerDipak R Delvadia David A ForsteinTeresa J BeaudoinRobert L BausermanMatt W YuenCarter A LittleApril Zambelli-Weiner

Published in: ClinicoEconomics and outcomes research : CEOR (2020)

TFA using the Sonata system has a significantly shorter operating room time and length of stay than myomectomy for the treatment of symptomatic uterine fibroids. All procedure, anesthesia, laboratory, pathology, and pharmacy costs were significantly higher for myomectomy as compared to TFA. TFA was also associated with significantly lower facility procedure-related costs compared to myomectomy, including inpatient, abdominal, or laparoscopic myomectomy.

Keyphrases

minimally invasive
palliative care
robot assisted
long term care
type diabetes
pregnant women
metabolic syndrome
combination therapy
acute care